Foundayo (Orforglipron) Approved in April 2026, Foundayo is a daily pill designed for weight loss
The treatment difference of 17.3 percentage points versus placebo represents the largest weight reduction achieved by any pharmacotherapy in a Phase 3 trial
Brighter, More Radiant Skin Customers consistently report a visible glow, improved brightness, and a more even complexion
123 As CBS and CSE use the same substrates to generate H 2 S, their function is interdependently regulated through substrate/product accumulation/depletion, which will favour one biochemical pathway over the other
Nasal Spray Melanotan 2 Nasal Spray Synthetic alpha-MSH analog nasal spray, 6mg total, 80 sprays at 75mcg per spray
Medicare Advantage plans Medicare does not cover medications prescribed specifically for weight loss